{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Variation in per-assay costs of clinical and WBE screening due to geospatial differences and labor costs.\",\"Impact\":\"Cost estimates may be inaccurate and lead to incorrect budgeting and resource allocation.\",\"Mitigation\":\"Conduct a thorough cost analysis that considers all factors contributing to per-assay costs, and adjust estimates for geospatial and labor cost variations.\",\"Technologies\":\"Cost analysis tools, geospatial analysis software, labor cost estimation tools.\",\"People\":\"Public health officials, healthcare administrators, researchers, policymakers.\",\"Owner\":\"Healthcare organizations, research institutions, government agencies.\"},{\"Description\":\"High SARS-CoV-2 load in wastewater, leading to elevated concentrations of viral genomes.\",\"Impact\":\"Increased risk of viral transmission through contaminated wastewater, posing a public health threat.\",\"Mitigation\":\"Implement robust wastewater treatment processes to reduce viral load, and monitor wastewater for early detection of viral presence.\",\"Technologies\":\"Advanced wastewater treatment systems, viral genome detection and monitoring technologies.\",\"People\":\"Public health officials, wastewater treatment professionals, policymakers.\",\"Owner\":\"Wastewater treatment facilities, public health authorities, government agencies.\"}]}"}}